ivermectin for humans, with its active ingredient ivermectin, has been investigated for its potential to reduce the transmission of parasitic diseases such as filariasis through targeted treatment interventions in endemic communities. By deploying preventive chemotherapy to at-risk populations, public health authorities aim to interrupt the cycle of transmission and prevent the spread of these debilitating diseases.
